By Craig Lammert, M.D. AIHA Executive Director Over the past decade, numerous studies have clearly shown that individuals with autoimmune hepatitis (AIH)...
Can a Lower Socioeconomic Status Worsen AIH?
read more
The Interface Blog.
The Interface Blog is the best place to find detailed perspectives on autoimmune hepatitis. We publish the most up-to-date news, educational pieces, and stories about patients just like you.
Subscribe to our blog
Is there a better medication than azathioprine to treat autoimmune hepatitis?
By Craig Lammert, M.D., AIHA Executive Director Azathioprine (Imuran) has reigned as the most common medication to treat autoimmune hepatitis (AIH) beyond steroids for...
Type 1 and Type 2 AIH May Not Be That Different After All
By Craig Lammert, M.D., AIHA Executive Director Two types of autoimmune hepatitis (AIH) have historically been recognized: Type 1 and Type 2. The type 2 variety,...
New Young Adult Support Group Launches
By the Autoimmune Hepatitis Association Two amazing young adults with AIH have stepped up to form a Young Adult Support Group for patients between the ages of 18...
The Bubonic Plague and Autoimmune Diseases
By Craig Lammert, M.D. AIHA Executive Director The bubonic plague often conjures images of flea bites and grotesque swollen lymph nodes. But when people think of the...
Budesonide vs. Prednisone in AIH: Which Medicine Wins?
The Autoimmune Hepatitis Association The treatment for autoimmune hepatitis (AIH) hasn’t changed much in the past 60 years; however, a newer steroid called budesonide...
Supporter Spotlight: Carol Joyce
During our 2022 Year-End Fundraising Campaign, we're sharing a series of Supporter Spotlights. We hope these stories of fellow autoimmune hepatitis (AIH) patients and...
Supporter Spotlight: Becki R.
During our 2022 Year-End Fundraising Campaign, we're sharing a series of Supporter Spotlights. We hope these stories of fellow autoimmune hepatitis (AIH) patients and...
Supporter Spotlight: Sara Hart
On GivingTuesday 2022, we wanted to share the first in a series of Supporter Spotlights we’ll be highlighting now through the end of the year. We hope these stories of...
Autoimmune Diseases and the Increased Risk of Cardiovascular Disease
The Autoimmune Hepatitis Association Research studies have long suggested that patients with autoimmune diseases may be at higher risk of cardiovascular disease such as...
The Latest Research on Metabolic Conditions in AIH Patients
The Autoimmune Hepatitis Association A research collaboration between Indiana University and University of Pennsylvania (which included members of the AIHA Medical...
Liver Injury after COVID-19 Vaccine: The Latest Findings
The Autoimmune Hepatitis Association This past year, a few cases have been reported of AIH developing and possible AIH flares after SARS-CoV-2 vaccination. Recently,...
AIH Can Negatively Impact Many Aspects of Life
The Autoimmune Hepatitis Association We are thrilled to share that the Autoimmune Hepatitis Association (AIHA) recently had its first patient-initiated research paper...
Autoimmune Hepatitis and Pregnancy
The Autoimmune Hepatitis Association We know it can be scary to think about having a baby when you have a rare disease, especially one like autoimmune hepatitis (AIH)...
New Data and Perspectives: Autoimmune Hepatitis Developing After COVID-19 Vaccines
By Craig Lammert, M.D., AIHA Executive Director Over the past year, a few members of the Autoimmune Hepatitis Association (AIHA) have emailed us or shared in our...